Status:
COMPLETED
Project Affinity: Excess Cancer Blood Testing
Lead Sponsor:
Entia Ltd
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Study investigating cancer blood samples on an iterative measurement systme
Eligibility Criteria
Inclusion
- Undergoing SACT
- Routine blood tests
Exclusion
- Not had first cycle of SACT
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
613 Patients enrolled
Trial Details
Trial ID
NCT04724005
Start Date
April 15 2021
End Date
August 31 2022
Last Update
September 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, United Kingdom